MAPK14 and colorectal carcinoma: Indeed, one controversial component of the CRC organoid medium is SB202190, a small-molecule, pyridinyl imidazole p38 MAP kinase inhibitor that directly binds p38 MAP kinases in the ATP binding pocket.